Price
$90.03
Decreased by -2.29%
Dollar Volume
40.78 M
ADR%
4.36
Earnings Report Date (estimate)
Feb 21, 23 (1)
Market Cap.
3.06 B
Shares Float
31.90 M
Shares Outstanding
32.49 M
Beta
0.97
Price / Earnings
25.36
BPR
6.84
20D Range
79.30 98.82
50D Range
79.30 98.82
200D Range
79.30 153.88
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Oct 27, 22 1.15
Decreased by -2.54%
1.22
Decreased by -5.74%
Oct 26, 22 1.15
Decreased by -24.84%
1.22
Decreased by -5.74%
Jul 27, 22 1.47
Decreased by -13.02%
1.23
Increased by +19.51%
Apr 27, 22 1.23
Decreased by -20.13%
1.12
Increased by +9.82%
Feb 23, 22 1.18
Decreased by -20.81%
1.18
Nov 2, 21 1.53
Decreased by -31.70%
1.37
Increased by +11.68%
Aug 4, 21 1.69
Increased by +26.12%
1.67
Increased by +1.20%
Apr 28, 21 1.54
Increased by +46.67%
1.43
Increased by +7.69%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 557.99 M
Increased by +0.81%
25.64 M
Decreased by -43.03%
Increased by +4.60%
Decreased by -43.49%
Jun 30, 22 557.89 M
Decreased by -1.11%
29.58 M
Decreased by -63.09%
Increased by +5.30%
Decreased by -62.68%
Mar 31, 22 545.26 M
Increased by +1.51%
31.67 M
Decreased by -36.49%
Increased by +5.81%
Decreased by -37.44%
Dec 31, 21 559.32 M
Increased by +1.56%
34.05 M
Decreased by -24.59%
Increased by +6.09%
Decreased by -25.75%
Sep 30, 21 553.49 M
Increased by +1.73%
45.01 M
Decreased by -37.48%
Increased by +8.13%
Decreased by -38.54%
Jun 30, 21 564.17 M
Increased by +16.31%
80.15 M
Increased by +131.15%
Increased by +14.21%
Increased by +98.74%
Mar 31, 21 537.14 M
Increased by +9.25%
49.87 M
Increased by +56.81%
Increased by +9.28%
Increased by +43.54%
Dec 31, 20 550.71 M
Increased by +9.99%
45.15 M
Increased by +63.27%
Increased by +8.20%
Increased by +48.43%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.